AA
AlphaCentric Advisors Portfolio holdings
AUM
$100M
This Quarter Return
+4.14%
1 Year Return
+18.84%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$100M
AUM Growth
+$100M
(-25%)
Cap. Flow
-$37.3M
Cap. Flow
% of AUM
-37.26%
Top 10 Holdings %
Top 10 Hldgs %
26.12%
Holding
294
New
64
Increased
34
Reduced
105
Closed
85
Top Buys
| 1 |
Eli Lilly
LLY
|
$4.74M |
| 2 |
UnitedHealth
UNH
|
$3.6M |
| 3 |
Johnson & Johnson
JNJ
|
$2.63M |
| 4 |
AbbVie
ABBV
|
$2.31M |
| 5 |
Thermo Fisher Scientific
TMO
|
$2.17M |
Top Sells
| 1 |
Rithm Capital
RITM
|
$4.32M |
| 2 |
Harmony Biosciences
HRMY
|
$3.88M |
| 3 |
Galapagos
GLPG
|
$3.12M |
| 4 |
EFC
Ellington Financial
EFC
|
$2.6M |
| 5 |
Neurocrine Biosciences
NBIX
|
$2.57M |
Sector Composition
| 1 | Healthcare | 54.58% |
| 2 | Real Estate | 7.4% |
| 3 | Industrials | 5.96% |
| 4 | Financials | 5.87% |
| 5 | Technology | 4.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
iShares JPMorgan EM High Yield Bond ETF
EMHY
$490M
| $378K | 0.38% |
9,956
+555
| +6% | +$21.1K |
|
77
Synchrony
SYF
$28.1B
| $375K | 0.37% |
5,766
-477
| -8% | -$31K |
|
78
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
$13.3B
| $375K | 0.37% |
4,208
+300
| +8% | +$26.7K |
|
79
Surgery Partners
SGRY
$2.9B
| $374K | 0.37% |
+17,684
| New | +$374K |
|
80
iShares Preferred and Income Securities ETF
PFF
$14.4B
| $369K | 0.37% |
11,744
+608
| +5% | +$19.1K |
|
81
SPDR Bloomberg Convertible Securities ETF
CWB
$4.4B
| $367K | 0.37% |
4,713
-121
| -3% | -$9.43K |
|
82
Vanguard High Dividend Yield ETF
VYM
$63.8B
| $365K | 0.36% |
2,858
+43
| +2% | +$5.49K |
|
|
AVDL
83
Avadel Pharmaceuticals
AVDL
$1.45B
| $354K | 0.35% |
+33,650
| New | +$354K |
|
84
Red Cat Holdings
RCAT
$887M
| $353K | 0.35% |
+27,500
| New | +$353K |
|
85
Regeneron Pharmaceuticals
REGN
$61.2B
| $350K | 0.35% |
+491
| New | +$350K |
|
86
C3.ai
AI
$2.31B
| $344K | 0.34% |
+10,000
| New | +$344K |
|
87
Myomo
MYO
$39.3M
| $322K | 0.32% |
50,000
| – | – |
|
88
iShares 7-10 Year Treasury Bond ETF
IEF
$35.5B
| $315K | 0.31% |
3,409
-414
| -11% | -$38.3K |
|
89
Arch Capital
ACGL
$34.1B
| $315K | 0.31% |
3,406
-181
| -5% | -$16.7K |
|
90
Tandem Diabetes Care
TNDM
$864M
| $292K | 0.29% |
+8,105
| New | +$292K |
|
91
Edgewise Therapeutics
EWTX
$1.57B
| $275K | 0.27% |
+10,316
| New | +$275K |
|
92
Protagonist Therapeutics
PTGX
$3.66B
| $275K | 0.27% |
7,123
-17,877
| -72% | -$690K |
|
93
Charles River Laboratories
CRL
$7.94B
| $272K | 0.27% |
+1,474
| New | +$272K |
|
94
Insmed
INSM
$30.7B
| $271K | 0.27% |
3,930
-1,070
| -21% | -$73.9K |
|
|
SELF
95
Global Self Storage
SELF
$60.2M
| $270K | 0.27% |
+50,722
| New | +$270K |
|
96
Applovin
APP
$163B
| $270K | 0.27% |
833
-146
| -15% | -$47.3K |
|
97
Sarepta Therapeutics
SRPT
$1.77B
| $269K | 0.27% |
2,211
-15,789
| -88% | -$1.92M |
|
98
Ionis Pharmaceuticals
IONS
$9.16B
| $266K | 0.27% |
+7,614
| New | +$266K |
|
99
PACCAR
PCAR
$51.9B
| $263K | 0.26% |
2,530
-239
| -9% | -$24.9K |
|
100
Apogee Therapeutics
APGE
$2.26B
| $256K | 0.26% |
5,649
-2,851
| -34% | -$129K |
|